Rebecca Urbanek
AstraZeneca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rebecca Urbanek.
Bioorganic & Medicinal Chemistry Letters | 2003
Dean G. Brown; Rebecca Urbanek; Thomas Michael Bare; Frances M. Mclaren; Carey Horchler; Megan Murphy; Gary Steelman; James Empfield; Janet Marie Forst; Keith J. Herzog; Wenhua Xiao; Martin C. Dyroff; Chi-Ming C. Lee; Shephali Trivedi; Kathy L. Neilson; Richard Alan Keith
Several members of the 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5H)-triones (2) have been identified as being potent and selective NMDA glycine-site antagonists. Increasing size of the alkyl substituent on the alpha-carbon led to a progressive decrease in binding affinity. Some of these analogues possess improved drug-like properties such as cellular permeability, solubility and oral absorption.
Bioorganic & Medicinal Chemistry Letters | 2013
Rebecca Urbanek; Hui Xiong; Ye Wu; William Blackwell; Gary Steelman; Jim Rosamond; Steven Wesolowski; James B. Campbell; Minli Zhang; Becky Brockel; Daniel V. Widzowski
Dopamine (D(2)) partial agonists (D2PAs) have been regarded as a potential treatment for schizophrenia patients with expected better side effect profiles than currently marketed antipsychotics. Herein we report the synthesis and SAR of a series of aminothiazole fused benzazepines as selective D(2) partial agonists. These compounds have good selectivity, CNS drug-like properties and tunable D(2) partial agonism. One of the key compounds, 8h, has good in vitro/in vivo ADME characteristics, and is active in a rat amphetamine-induced locomotor activity model.
ACS Medicinal Chemistry Letters | 2013
Dean G. Brown; Peter R. Bernstein; Ye Wu; Rebecca Urbanek; Christopher Becker; Scott Throner; Bruce T. Dembofsky; Gary Steelman; Lois Ann Lazor; Clay W Scott; Michael W. Wood; Steven Wesolowski; David A. Nugiel; Stephanie Koch; Jian Yu; Donald E. Pivonka; Shuang Li; Carol Thompson; Anna Zacco; Charles S. Elmore; Patricia Schroeder; Jianwei Liu; Christopher Hurley; Stuart Ward; Hazel J. Hunt; Karen Williams; Joseph McLaughlin; Valerie Hoesch; Simon Sydserff; Donna L. Maier
Herein, we describe the discovery of inhibitors of norepinephrine (NET) and dopamine (DAT) transporters with reduced activity relative to serotonin transporters (SERT). Two compounds, 8b and 21a, along with nomifensine were tested in a rodent receptor occupancy study and demonstrated dose-dependent displacement of radiolabeled NET and DAT ligands. These compounds were efficacious in a rat forced swim assay (model of depression) and also had activity in rat spontaneous locomotion assay.
Angewandte Chemie | 1999
Amy B. Dounay; Rebecca Urbanek; Steven F. Sabes; Craig J. Forsyth
Eine nur kleine Veranderung an der Struktur von Okadasaure 1, das Fehlen der Hydroxygruppe an C7, fuhrt zum praparativ erheblich besser zuganglichen Derivat 7-Desoxyokadasaure 2. Die Konformation von 2 stimmt mit der von 1 uberein, und die Wirkung als Inhibitor der Serin/Threonin-spezifischen Proteinphosphatasen PP-1 und PP-2A wird, wie kurzlich berichtet wurde, durch diese minimale Strukturvariation kaum beeinflust.
Drug Metabolism and Disposition | 2015
Minli Zhang; Ryan J. Eismin; Hilkka I. Kenttämaa; Hui Xiong; Ye Wu; Doug Burdette; Rebecca Urbanek
2-Aminothiazolobenzazepine (2-ATBA), 7-[(1-methyl-1H-pyrazol-4-yl)methyl]-6,7,8,9-tetrahydro-5H-[1,3]thiazolo[4,5-h][3]benzazepin-2-amine, is a D2 partial agonist that has demonstrated antipsychotic effects in a rodent in vivo efficacy model. The metabolite profile showed that 2-ATBA is mainly metabolized by oxidation. However, identification of the oxidation site(s) in the 2-aminothiazole group presents a challenge for the traditional metabolite identification methods such as liquid chromatography/mass spectrometry and NMR due to the lack of unique tandem mass spectrometry fragmentation patterns for ions with the 2-aminothiazole group oxidized at different sites and the lack of stability for purification or reference standard synthesis. We describe the characterization of the oxidized heteroatoms of the 2-aminothiazole group via gas-phase ion-molecule reactions (GPIMR) in a modified linear quadrupole ion trap mass spectrometer. The GPIMR reagents used were dimethyl disulfide, tert-butyl peroxide, and tri(dimethylamino)borane. Each reagent was introduced into the ion trap through the helium line and was allowed to react with the protonated metabolites. The ionic ion-molecule reaction products and their fragmentation profiles were compared with the profiles of the ionic ion-molecule reaction products of protonated reference compounds that had specific heteroatom functionalities. The oxidized 2-aminothiazole metabolite of 2-ATBA showed a similar GPIMR profile to that of the reference compounds with a tertiary N-oxide functionality and distinct from the profiles of the reference compounds with N-aryl hydroxylamine, nitroso, or pyridine N-oxide functionalities. This study demonstrates the feasibility of fingerprinting the chemical nature of oxidized nitrogen functional groups via GPIMR profiling for metabolite structure elucidation.
Archive | 2005
Joshua Clayton; Fupeng Ma; Bradford Van Wagenen; Radhakrishnan Ukkiramapandian; Ian Egle; James Empfield; Methvin Isaac; Abdelmalik Slassi; Gary Steelman; Rebecca Urbanek; Sally Walsh
Journal of Medicinal Chemistry | 2001
Rebecca Urbanek; Suzanne J. Suchard; Gary Steelman; Katharine S. Knappenberger; Linda A. Sygowski; Chris Allan Veale; Marc Chapdelaine
Archive | 2006
Bradford Van Wagenen; Radhakrishnan Ukkiramapandian; Joshua Clayton; Ian Egle; James Empfield; Methvin Isaac; Fupeng Ma; Abdelmalik Slassi; Gary Steelman; Rebecca Urbanek; Sally Walsh
Archive | 2006
Bradford Van Wagenen; Radhakrishnan Ukkiramapandian; Joshua Clayton; Ian Egle; James Empfield; Methvin Isaac; Fupeng Ma; Abdelmalik Slassi; Gary Steelman; Rebecca Urbanek; Sally Walsh
Journal of the American Chemical Society | 1998
Steven F. Sabes; Rebecca Urbanek; Craig J. Forsyth